Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2
US-2024239874-A2 · Jul 18, 2024 · US
This page is not indexed by search engines while we improve data quality.
Patent family 89510537
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 89510537 |
| Family type | — |
| Earliest priority | Jun 29, 2022 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US2024239874A2 — Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2 |
Representative publication
Best representative member for this family based on priority and filing country.
US2024239874A2 — Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2 (published Jul 18, 2024)
Member publications
Related publications in this family.